Wataru Okamoto

Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies

Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda et al. · Nature Medicine · 2020 · 347 citations

Scrum-japan Gi-screen, Oncology, Gastrointestinal Oncology +13

Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial

Yoshiaki Nakamura, Wataru Okamoto, Takeshi Kato et al. · Nature Medicine · 2021 · 233 citations · Full text

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Shubham Pant, Martin Schüler, Gopa Iyer et al. · The Lancet Oncology · 2023 · 175 citations · Full text

Fgfr Alterations, Medicine, Pathology +7

TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study

Yasutoshi Kuboki, Tomohiro Nishina, Eiji Shinozaki et al. · The Lancet Oncology · 2017 · 171 citations

Phase 1/2, Gastrointestinal Oncology, Medicine +6

Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer

Ken Takezawa, Isamu Okamoto, Wataru Okamoto et al. · British Journal of Cancer · 2011 · 168 citations · Full text